Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali

Background. In 2010, Africa's first preventive meningococcal mass vaccination campaign was launched using a newly developed Neisseria meningitidis group A (NmA) polysaccharide–tetanus toxoid conjugate vaccine, PsA-TT (MenAfriVac), designed specifically for the meningitis belt. Given PsA-TT'...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Dembélé, Awa Traoré Eps, Onwuchekwa, Uma, Townsend, Kelly, Boukary, Rahamatou M., Mabey, Lesley, Findlow, Helen, Bai, Xilian, Sow, Samba O.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639504/
https://ncbi.nlm.nih.gov/pubmed/26553687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ602
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi